Zobrazeno 1 - 10
of 21
pro vyhledávání: '"N V Molashenko"'
Autor:
B M Shifman, N M Platonova, N V Molashenko, E A Troshina, I I Sitkin, D G Belcevich, L D Kovalevich, N Yu Romanova, G S Kolesnikova
Publikováno v:
Терапевтический архив, Vol 91, Iss 10, Pp 91-99 (2019)
Primary hyperaldosteronism (PA) - is the clinical syndrome, results from autonomous of the major regulators of secretion, aldosterone overproduction by a tumorous or hyperplastic tissue in adrenal cortex. Being the most frequent cause of secondary hy
Externí odkaz:
https://doaj.org/article/e6c88c1df6ed48148f4407f645244772
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 2, Pp 26-28 (2014)
Congenital adrenal hyperplasia (CAH) is a disease leading to decreased adrenal cortisol secretion which requires lifelong treatment with glucocorticoids (GC). However the question whether these patients need regular DXA screening for osteoporosis is
Externí odkaz:
https://doaj.org/article/5431c6bb357c4fb9b4399c092ecf179a
Autor:
K. V. Ivashchenko, K. A. Komshilova, N. V. Molashenko, A. A. Lavreniuk, A. M. Lapshina, I. V. Kim, V. A. Ioutsi, M. A. Antsupova, M. V. Utkina, N. M. Platonova, E. A. Troshina, N. G. Mokrysheva
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 4, Pp 363-370 (2024)
Hyperandrogenism is the most prevalent cause of menstrual cycle abnormalities and infertility in women. Here, we present a case of a 32-year-old woman with a 7-year history of menstrual irregularity and infertility. Laboratory test results revealed e
Externí odkaz:
https://doaj.org/article/87861a79039b46e1aeee5377fbf9576e
Autor:
N. V. Molashenko, N. Yu. Kalinchenko, V. A. Ioutsi, O. S. Gurinovich, D. M. Babaeva, A. A. Voznesenskaya, N. M. Platonova, M. Yu. Yukina, A. A. Kolodkina, T. A. Ponomareva
Publikováno v:
Obesity and metabolism. 20:73-83
17β-Hydroxysteroid dehydrogenase 3 deficiency (17HSD3) is a rare autosomal recessive cause of 46, XY disorders of sex development resulting from HSD17B3 gene mutations, in which conversion of androstenedione to testosterone is impared. The clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da4931715c41744c4c7f92c39d0766d1
https://doi.org/10.14341/omet12942
https://doi.org/10.14341/omet12942
Autor:
L. V. Suturina, L. A. Suplotova, Elena Valer'evna Biryukova, M. I. Yarmolinskaya, E A Troshina, Galina A. Melnichenko, L. V. Adamyan, N. V. Molashenko, Natalya Mokrysheva, V V Fadeev, R. M. Esayan, B. M. Shifman, T. P. Kiseleva, M. B. Antsiferov, Maria Kareva, A I Sazonova, E V. Uvarova, E. N. Andreeva, Z. A. Uzhegova, N. Yu. Kalinchenko
Publikováno v:
Ожирение и метаболизм, Vol 18, Iss 3, Pp 345-382 (2021)
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive diseases characterized by a defect in one of the enzymes or transport proteins involved in the cortisol synthesis in the adrenal cortex. The most common form of CAH, which occurs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f167e8170680ecaa80e7319455ed672
https://doi.org/10.14341/omet12787
https://doi.org/10.14341/omet12787
Autor:
N. Yu. Sviridenko, N. M. Platonova, N. V. Molashenko, S. P. Golitsyn, S. A. Bakalov, S. E. Serdyuk
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 63-71 (2012)
This review discusses the effects of amiodarone on thyroid function and summarises the results of international studies and the evidence obtained by the researchers from the A.L. Myasnikov Research Institute of Clinical Cardiology and Endocrinology R
Externí odkaz:
https://doaj.org/article/9e85b8a6add44482ab830d70374f86ca
Publikováno v:
Consilium Medicum. 19:70-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37e7e4b4da2f644736d8fc7ef56f48e6
https://doi.org/10.26442/2075-1753_19.4.70-74
https://doi.org/10.26442/2075-1753_19.4.70-74
Publikováno v:
Consilium Medicum. 18:8-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61588cf9aac69f0cee20574175b23073
https://doi.org/10.26442/2075-1753_2016.4.8-19
https://doi.org/10.26442/2075-1753_2016.4.8-19
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 2, Pp 26-28 (2014)
Congenital adrenal hyperplasia (CAH) is a disease leading to decreased adrenal cortisol secretion which requires lifelong treatment with glucocorticoids (GC). However the question whether these patients need regular DXA screening for osteoporosis is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7047afb51c44b63d587340065755901f
https://doi.org/10.14341/osteo2014226-28
https://doi.org/10.14341/osteo2014226-28
Publikováno v:
Problems of Endocrinology. 58:3-9
A total of 55 patients at the age from 18 to 60 years presenting with the classical forms of congenital adrenal hyperplasia (CAH) were available for the estimation of the body mass index (BMI), measurement of AP, glycemia in OGTT, insulin level, HOMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83d000193456079e3f4256a9a10e943e
https://doi.org/10.14341/probl20125853-9
https://doi.org/10.14341/probl20125853-9